Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
30
2026

How 2026 Code Changes Shifted SRT from Sensus Healthcare to a Standard Treatment Option

For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…

November
12
2015

SRT-100™: The Non-Surgical Choice Among Skin Cancer Treatment Options

When you are diagnosed with skin cancer, the first question you ask is, “What are my options?” You are given several options, including Mohs micrographic surgery, excisional surgery, electrosurgery, cryosurgery, and more choices that all…

October
27
2015

Sensus Healthcare Introduces Superficial Radio Therapy By The SRT-100™ As A Mobile Unit For Doctors

Sensus Healthcare is revolutionizing skin cancer treatment with the SRT-100™, a Superficial Radio Therapy machine that provides a non-surgical option for treatment of non-melanoma cancer. There is now a mobile unit of the SRT-100™ available….

October
27
2015

Sensus Healthcare Introduces Superficial Radiotherapy As A Mobile Unit For Immobile Patients

Sensus Healthcare is revolutionizing skin cancer treatment with the SRT-100™, a Superficial Radiotherapy machine that provides a non-surgical option for treatment of non-melanoma cancer. There is now a mobile unit of the SRT-100™ available, allowing…

September
23
2015

Sensus Healthcare: Treating Keloids

11 million people suffer from keloids. A keloid is a growth of extra scar tissue where the skin has healed after an injury. Keloids expand in claw-like growths over normal skin. They have the capability…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry